Generation Bio Pre-Tax Profit Margin 2020-2023 | GBIO
Generation Bio Pre-Tax Profit Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical - Generic Drugs | $0.193B | $0.006B |
Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Teva Pharmaceutical Industries (TEVA) | Israel | $15.482B | 5.59 |
Dr Reddy's Laboratories (RDY) | India | $12.441B | 19.67 |
Aspen Pharmacare (APNHY) | South Africa | $5.038B | 0.00 |
BridgeBio Pharma (BBIO) | United States | $4.656B | 0.00 |
Bausch Health Cos (BHC) | Canada | $3.183B | 2.48 |
Amphastar Pharmaceuticals (AMPH) | United States | $2.009B | 13.75 |
Supernus Pharmaceuticals (SUPN) | United States | $1.646B | 0.00 |
Taysha Gene Therapies (TSHA) | United States | $0.447B | 0.00 |
Assembly Biosciences (ASMB) | United States | $0.069B | 0.00 |
Personalis (PSNL) | United States | $0.064B | 0.00 |
Acasti Pharma (ACST) | Canada | $0.027B | 0.00 |
Sol-Gel Technologies (SLGL) | Israel | $0.025B | 0.00 |
Evoke Pharma (EVOK) | United States | $0.004B | 0.00 |
Teligent (TLGT) | United States | $0.000B | 0.00 |